Keyphrases
Extensively Drug-resistant
100%
Genotypic Characterization
100%
Antimicrobial
100%
Resistance Factor
100%
Gram-negative Bacilli
100%
Synergistic Antibacterial
100%
Antimicrobial Combinations
100%
Oman
100%
Pandrug-resistant
100%
Time-kill Assay
50%
Tigecycline
50%
Amikacin
50%
Antibiotic Combination
50%
Chequerboard
50%
Bioassay Test
50%
Levofloxacin
50%
E-test
50%
Synergistic Response
50%
NDM-1
50%
Timely Decisions
50%
Trimethoprim-sulfamethoxazole (TMP-SMX)
50%
Sick
50%
Minocycline
50%
Fosfomycin
50%
New Antibiotics
50%
Synergistic Interaction
50%
Patient Care
50%
Escherichia Coli
50%
Bacterial Infection
50%
Colistin
50%
Patient Mortality
50%
Patient Morbidity
50%
OXA-48
50%
Acinetobacter Baumannii (A. baumannii)
50%
Pseudomonas Aeruginosa (P. aeruginosa)
50%
Carbapenems
50%
Klebsiella Pneumoniae (K. pneumoniae)
50%
Antibiotics
50%
Informed Decision Making
50%
Antimicrobial Resistance
50%
Medicine and Dentistry
Antiinfective Agent
100%
In Vitro
100%
Antibiotics
100%
Gram-Negative Bacteria
100%
Klebsiella pneumoniae
33%
Clinician
33%
Carbapenem Derivative
33%
Pseudomonas aeruginosa
33%
Fosfomycin
33%
Bacterial Infection
33%
Inosine Phosphate
33%
Acinetobacter Baumannii
33%
Levofloxacin
33%
Escherichia coli
33%
Patient Care
33%
Tigecycline
33%
Minocycline
33%
Antibiotic Resistance
33%
Amikacin
33%
Trimethoprim/Sulfamethoxazole
33%
Colistimethate
33%
Pharmacology, Toxicology and Pharmaceutical Science
Gram Negative Bacterium
100%
Antibiotic Agent
100%
Antiinfective Agent
100%
Tigecycline
33%
Fosfomycin
33%
Antimicrobial Resistance
33%
Levofloxacin
33%
Klebsiella pneumoniae
33%
Cotrimoxazole
33%
Amikacin
33%
Escherichia coli
33%
Carbapenem Derivative
33%
Colistimethate
33%
Bacterial Infection
33%
Minocycline
33%
Pseudomonas aeruginosa
33%
Acinetobacter Baumannii
33%
Inosine Phosphate
33%